John Mascarenhas, MD

Treatment of Chronic Idiopathic Myelofibrosis

John Mascarenhas , MD;

08/29/2020

Conference Coverage

Utilizing and Selecting Optimal JAK Inhibitor Therapies for Patients With Myelofibrosis

09/12/2024

John Mascarenhas , MD;

At the 2024 SOHO meeting, John Mascarenhas, MD, shares highlights from a discussion on the utilization and selection of optimal JAK inhibitor therapies for the treatment of patients with myelofibrosis.

At the 2024 SOHO meeting, John...

09/12/2024

Oncology

Conference Coverage

New and Upcoming Combination and Non-JAK Inhibitor Treatments for Patients With Myelofibrosis

09/12/2024

John Mascarenhas , MD;

At the 2024 SOHO meeting, John Mascarenhas, MD reviewed the latest data in myelofibrosis treatment options, including upcoming novel combination and non-JAK inhibitor therapies.

At the 2024 SOHO meeting, John...

09/12/2024

Oncology